Arecor targets phase II insuling trial for 2026 after successful 2025
Proactive - Interviews for investors · Proactive Investors
February 11, 20269m 22s
Audio is streamed directly from the publisher (cdn.simplecast.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.